Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Starbucks Corp. sell BiotechBee

Start price
€86.57
22.09.22 / 60%
Target price
€75.00
31.12.24
Performance (%)
5.46%
End price
€91.30
21.12.22
Summary
This prediction ended on 21.12.22 with a price of €91.30. With a performance of 5.46%, the SELL prediction by BiotechBee for Starbucks Corp. was trending in the wrong direction A total of €0.53 was paid as dividends for this prediction. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Starbucks Corp. 2.064% 2.064% -16.670%
iShares Core DAX® 2.112% -0.367% 13.466%
iShares Nasdaq 100 -2.197% -3.794% 38.426%
iShares Nikkei 225® -1.555% -7.320% 18.451%
iShares S&P 500 -0.472% -2.078% 27.488%

According to BiotechBee what are the pros and cons of Starbucks Corp. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by BiotechBee for this prediction

In the thread Starbucks Corp. diskutieren
Prediction Sell
Perf. (%) 5.46%
Target price 75.000
Change
Ends at 31.12.24

Sell mit Kursziel 75,0

In the thread Trading Starbucks Corp.
Prediction Sell
Perf. (%) 5.46%
Target price 75.000
Change
Ends at 31.12.24

Sell beendet